BackgroundCheck.run
Search For

Jagdish S Desai, 7955 Oak Shade Rd, Gaithersburg, MD 20878

Known as:
Jagdish M Desai Bhavna J Desai H Desai
Related to:
James A Jones 88

Jagdish Desai Phones & Addresses

55 Oak Shade Rd, Gaithersburg, MD 20878    301-3309309   

Brooklyn, NY   

Yonkers, NY   

Jamaica, NY   

Education

Degree: High school graduate or higher
Get Report
Control this profile

Mentions for Jagdish S Desai

Career records & work history

Medicine Doctors

Jagdish B. Desai

Specialties:
Pediatrics
Work:
University Of Mississippi Medical Center
2500 N State St, Jackson, MS 39216
601-9841000 (phone) 601-8150436 (fax)
Education:
Medical School
Gov't Med Coll Bhavnagar, Bhavnagar Univ, Bhavnagar, New Delhi, India
Graduated: 2006
Conditions:
Atopic Dermatitis
Languages:
English
Description:
Dr. Desai graduated from the Gov't Med Coll Bhavnagar, Bhavnagar Univ, Bhavnagar, New Delhi, India in 2006. He works in Jackson, MS and specializes in Pediatrics.
Jagdish Desai Photo 1

Jagdish Desai

Specialties:
Pediatrics

Publications & IP owners

Us Patents

Farnesyl Protein Transferase Inhibitors As Antitumor Agents

US Patent:
7342016, Mar 11, 2008
Filed:
Dec 19, 2002
Appl. No.:
10/325896
Inventors:
Hugh Y. Zhu - Scotch Plains NJ, US
F. George Njoroge - Warren NJ, US
Alan B. Cooper - West Caldwell NJ, US
Timothy J. Guzi - Chatham NJ, US
Dinanath F. Rane - Morganville NJ, US
Keith P. Minor - Sayerville NJ, US
Ronald J. Doll - Convent Station NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Bama Santhanam - Bridgewater NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
Kartik M. Keertikar - East Windsor NJ, US
Carmen S. Alvarez - Roselle Park NJ, US
John J. Baldwin - Gwynedd Valley PA, US
Ge Li - Shanghai, CN
Chia-Yu Huang - Plainsboro NJ, US
Ray A. James - Plainsboro NJ, US
James J-S Wang - Westfield NJ, US
Jagdish A. Desai - Monroe Township NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Pharmacopeia, Inc. - Cranbury NJ
International Classification:
A61K 31/497
A61K 31/44
C07D 401/14
C07D 221/06
US Classification:
51425304, 514290, 544361, 546 93
Abstract:
Disclosed are novel tricyclic compounds represented by the formula (1. 0):.

Substituted 5-Carboxyamide Pyrazoles And [1,2,4]Triazoles As Antiviral Agents

US Patent:
7425640, Sep 16, 2008
Filed:
Oct 26, 2005
Appl. No.:
11/259399
Inventors:
Alan B. Cooper - West Caldwell NJ, US
Hugh Y. Zhu - Scotch Plains NJ, US
James J-S Wang - Westfield NJ, US
Jagdish A. Desai - Monroe Township NJ, US
Patrick J. Curran - Winthrop MA, US
D. Allen Annis - Cambridge MA, US
Huw M. Nash - Cambridge MA, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 231/00
A61K 31/41
A61K 31/415
US Classification:
5483741, 5483717, 5483697, 514381, 514406, 514407
Abstract:
The present invention provides compounds of formula I wherein X, Y, R-Rare as defined herein. Compositions containing these compounds, and methods for inhibiting HCV RNA-dependent RNA polymerase and treating hepatitis C and related disorders using these compounds and compositions are also provided.

Farnesyl Protein Transferase Inhibitors As Antitumor Agents

US Patent:
7557107, Jul 7, 2009
Filed:
Aug 4, 2004
Appl. No.:
10/911340
Inventors:
Hugh Y. Zhu - Scotch Plains NJ, US
Alan B. Cooper - West Caldwell NJ, US
Jagdish A. Desai - Monroe Township NJ, US
James J-S Wang - Westfield NJ, US
Ronald J. Doll - Convent Station NJ, US
F. George Njoroge - Warren NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Assignee:
Schering Coporation - Kenilworth NJ
International Classification:
A61K 31/497
US Classification:
51425303, 544361
Abstract:
Disclosed are novel tricyclic compounds of the formula:.

Compounds That Are Erk Inhibitors

US Patent:
8546404, Oct 1, 2013
Filed:
Jun 5, 2007
Appl. No.:
11/810282
Inventors:
Alan B. Cooper - West Caldwell NJ, US
Yongqi Deng - Newton MA, US
Neng-Yang Shih - Lexington MA, US
Hugh Y. Zhu - Scotch Plains NJ, US
Robert Sun - Natick MA, US
Joseph M. Kelly - Parlin NJ, US
Ronald J. Doll - Convent Station NJ, US
Yang Nan - Malden MA, US
Tong Wang - Cambridge MA, US
Jagdish A. Desai - Monroe Township NJ, US
James J-S Wang - Westfield NJ, US
Youhao Dong - Cambridge MA, US
Vincent S. Madison - Mountain Lakes NJ, US
Li Xiao - Cranbury NJ, US
Alan W. Hruza - Hackettstown NJ, US
M. Arshad Siddiqui - Newton MA, US
Ahmed A. Samatar - West Windsor NJ, US
Sunil Paliwal - Monroe Township NJ, US
Azim Alan Celebi - Clark NJ, US
Yiji Wu - Scotch Plains NJ, US
Sobhana Babu Boga - Scotch Plains NJ, US
Abdul-Basit Alhassan - Scotch Plains NJ, US
Xiaolei Gao - Scotch Plains NJ, US
Liang Zhu - Somerville MA, US
Mehul Patel - Waltham MA, US
Assignee:
Merck Sharp & Dohme - Rahway NJ
International Classification:
A01N 43/54
C07D 239/42
C07D 401/04
US Classification:
514256, 514247, 514277, 514396, 544315, 546 1, 546184, 5463611, 5483561, 5483601
Abstract:
Disclosed are the ERK inhibitors of formula 1. 0:.

Novel Farnesyl Protein Transferase Inhibitors As Antitumor Agents

US Patent:
2003022, Dec 11, 2003
Filed:
Feb 27, 2002
Appl. No.:
10/085896
Inventors:
Hugh Zhu - Scotch Plains NJ, US
F. Njoroge - Warren NJ, US
Alan Cooper - West Caldwell NJ, US
Timothy Guzi - Chatham NJ, US
Dinanath Rane - Morgansville NJ, US
Keith Minor - Sayreville NJ, US
Ronald Doll - Convent Station NJ, US
Viyyoor Girijavallabhan - Parsippany NJ, US
Bama Santhanam - Bridgewater NJ, US
Patrick Pinto - Morris Plains NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
Kartik Keertikar - Rahway NJ, US
Carmen Alvarez - Roselle Park NJ, US
John Baldwin - Gwynedd Valley PA, US
Ge Li - ShangHai, CN
Chia-Yu Huang - Plainsboro NJ, US
Ray James - Plainsboro NJ, US
W. Bishop - Pompton Plains NJ, US
James Wang - Westfield NJ, US
Jagdish Desai - Monroe Township NJ, US
International Classification:
A61K031/496
A61K031/473
C 07D 4 3/02
C 07D 4 1/02
US Classification:
514/253030, 514/290000, 544/361000, 546/093000
Abstract:
Disclosed are novel tricyclic compounds represented by the formula (1.0): or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.

Novel Farnesyl Protein Transferase Inhibitors As Antitumor Agents

US Patent:
2006020, Sep 14, 2006
Filed:
Dec 19, 2005
Appl. No.:
11/311052
Inventors:
Alan Cooper - West Caldwell NJ, US
Hugh Zhu - Scotch Plains NJ, US
James Wang - Westfield NJ, US
Jagdish Desai - Monroe Township NJ, US
International Classification:
A61K 31/473
C07D 401/14
US Classification:
514290000, 546093000
Abstract:
Disclosed are novel tricyclic compounds of the formula: and the pharmaceutically acceptable salts thereof. Y is C or CH. When Y is C then Z is not present and the optional bond from Y to the C-11 carbon of the tricyclic nucleus is present. When Y is CH then Z is present and Z is H or —OH. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising the compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.

Novel Compounds That Are Erk Inhibitors

US Patent:
2007019, Aug 16, 2007
Filed:
Dec 11, 2006
Appl. No.:
11/636954
Inventors:
Alan Cooper - West Caldwell NJ, US
Yongqi Deng - Newton MA, US
Gerald Shipps - Stoneham MA, US
Neng-Yang Shih - Warren NJ, US
Hugh Zhu - Scotch Plains NJ, US
Robert Sun - Berkeley Heights NJ, US
Joseph Kelly - Cambridge MA, US
Ronald Doll - Convent Station NJ, US
Yang Nan - Malden MA, US
Tong Wang - Cambridge MA, US
Jagdish Desai - Monroe Township NJ, US
James Wang - Westfield NJ, US
Youhao Dong - Cambridge MA, US
Vincent Madison - Mountain Lakes NJ, US
Li Xiao - Cranbury NJ, US
Alan Hruza - Hackettstown NJ, US
M. Siddiqui - Newton MA, US
Ahmed Samatar - West Windsor NJ, US
Sunil Paliwal - Monroe Township NJ, US
Azim Celebi - Clark NJ, US
Yiji Wu - Scotch Plains NJ, US
Sobhana Boga - Scotch Plains NJ, US
International Classification:
C07D 417/14
C07D 413/14
C07D 403/14
US Classification:
544060000, 544372000, 544140000, 546199000, 548361100
Abstract:
Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.

Novel Compounds That Are Erk Inhibitors

US Patent:
2011018, Aug 4, 2011
Filed:
Feb 19, 2009
Appl. No.:
12/918099
Inventors:
Alan B. Cooper - Kenilworth NJ, US
Yang Nan - Cambridge MA, US
Yongqi Deng - Cambridge MA, US
Neng-Yang Shih - Cambridge MA, US
Hugh Y. Zhu - Kenilworth NJ, US
Joseph M. Kelly - Kenilworth NJ, US
Subrahmanyam Gudipati - Kenilworth NJ, US
Ronald J. Doll - Kenilworth NJ, US
Mehul F. Patel - Cambridge MA, US
Jagdish A. Desai - Kenilworth NJ, US
James J-S Wang - Kenilworth NJ, US
Sunil Paliwal - Kenilworth NJ, US
Sobhana Babu Boga - Kenilworth NJ, US
Abdul-Basit Alhassan - Kenilworth NJ, US
Xiaolei Gao - Kenilworth NJ, US
Liang Zhu - Cambridge MA, US
Xin Yao - Kenilworth NJ, US
International Classification:
A61K 31/444
C07D 401/14
C07D 409/14
C07D 417/14
A61K 31/501
A61K 39/395
A61K 31/7052
A61P 35/02
A61P 35/00
US Classification:
4241581, 546256, 544238, 514333, 51425203, 514 43, 4241721
Abstract:
Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.

Possible Relatives

Daxa M Desai  Daksha A Desai  Aakash R Desai  Deepa A Desai  Deepak N Desai  Deepika H Desai  Darshak R Desai  Jagdish Mitter  Jagdish Patel  Jagdish Rao 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.